ORKA Q4 2023 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$23,000

Operating Income

-$2M

Net Income

-$1M

EPS (Diluted)

$-0.90

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$38M

Total Liabilities

$841,000

Stockholders' Equity

$37M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$23,000	-$29,000	+20.7%
Operating Income	-$2M	-$2M	-0.4%
Net Income	-$1M	-$1M	+7.2%